DHTI (Dalrada Technology Group) 3-Year EBITDA Growth Rate: -11.60% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Dalrada Technology Group 3-Year EBITDA Growth Rate?

Dalrada Technology Group DHTI 3-Year EBITDA Growth Rate is -11.60% as of Mar. 2026. The stock has 8 warning signs investors should review. Among 527 Healthcare Providers & Services companies, Dalrada Technology Group ranks worse than 83.3% on this metric.

Dalrada Technology Group's EBITDA per Share for the three months ended in Mar. 2026 was $-0.03.

During the past 3 years, the average EBITDA Per Share Growth Rate was -11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Dalrada Technology Group was 81.00% per year. The lowest was -105.10% per year. And the median was 55.55% per year.


Dalrada Technology Group  (OTCPK:DHTI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Dalrada Technology Group 3-Year EBITDA Growth Rate Related Terms


DHTI vs RDGT, PMHS, BLMH: 3-Year EBITDA Growth Rate Comparison

For the Pharmaceutical Retailers subindustry, Dalrada Technology Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dalrada Technology Group 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dalrada Technology Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Dalrada Technology Group's 3-Year EBITDA Growth Rate falls into.



Dalrada Technology Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of -11.60% mean?
Dalrada Technology Group (DHTI) has a 3-Year EBITDA Growth Rate of -11.60% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Dalrada Technology Group and its competitors. According to the industry distribution chart, Dalrada Technology Group ranks #439 out of 527 companies in the Healthcare Providers & Services industry, placing it in the top 83.3%.
Is Dalrada Technology Group's 3-Year EBITDA Growth Rate too high?
Dalrada Technology Group's current 3-Year EBITDA Growth Rate is -11.60%. Based on the distribution chart, Dalrada Technology Group ranks #439 out of 527 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Dalrada Technology Group's 3-Year EBITDA Growth Rate compare to RDGT and PMHS?
According to the Healthcare Providers & Services industry distribution chart, Dalrada Technology Group ranks #439 out of 527 companies for 3-Year EBITDA Growth Rate. This places Dalrada Technology Group in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 527 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Dalrada Technology Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dalrada Technology Group's current 3-Year EBITDA Growth Rate is -11.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dalrada Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dalrada Technology Group (DHTI) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.02 — trading 65% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -11.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Dalrada Technology Group (DHTI), the current 3-Year EBITDA Growth Rate is -11.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dalrada Technology Group Business Description

Address 600 La Terraza Boulevard, Escondido, CA, USA, 92025
Dalrada Technology Group Inc is a United States-based company engaged in providing commercial and home heat pumps, building advanced physical deposition solutions for semiconductor manufacturers and clean energy applications, and driving enhanced healthcare initiatives through its subsidiaries like specialty pharmacy. Its business segments include: Climate Technology; Deposition Technology; and Genefic Healthcare.